Literature DB >> 31959320

The Affordable Care Act and Ethnic Disparities in Colorectal Cancer Screening.

Olive M Mbah1, Alan C Kinlaw2, Justin G Trogdon3, Stephanie B Wheeler3, Cleo A Samuel3.   

Abstract

INTRODUCTION: Cost sharing can deter the use of health services and act as a potential contributor to racial/ethnic disparities in cancer. The Affordable Care Act required most health plans to cover, without cost sharing, preventive services, including colorectal cancer screening. Population-based data were used to estimate the impact of the Affordable Care Act's cost-sharing provision (together with other Affordable Care Act provisions targeting preventive care) on ethnic disparities in colorectal cancer screening, comparing Hispanics with non-Hispanics.
METHODS: An interrupted time series quasi-experimental analysis was used to examine ethnic differences in colorectal cancer screening pre- and post-implementation of the Affordable Care Act (analysis performed in 2018). The study cohort included insured individuals aged 50-64 years who participated in the Medical Expenditure Panel Survey from 2007 through 2015 (n=44,343).
RESULTS: During the pre-Affordable Care Act period, screening rates decreased annually for non-Hispanics by -0.38 per 100 adults per year (95% CI= -0.55, -0.22) but remained level for Hispanics (annual trend per 100 adults: 0.01, 95% CI= -0.34, 0.35). After cost sharing was eliminated in 2011, colorectal cancer screening rates increased for both Hispanics (by 1.29 per 100 adults, 95% CI=0.69, 1.89) and non-Hispanics (by 0.58 per 100 adults, 95% CI=0.18, 0.99). The difference in trend increases between Hispanics and non-Hispanics was not statistically significant (0.70%, 95% CI= -0.24, 1.64).
CONCLUSIONS: These findings suggest that Affordable Care Act implementation resulted in increased colorectal cancer screening; however, the effect of the law was not significantly different between Hispanics and non-Hispanics. These results provide indications that more needs to be done to reduce racial/ethnic disparities in colorectal cancer screening.
Copyright © 2019 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 31959320     DOI: 10.1016/j.amepre.2019.09.002

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  6 in total

Review 1.  Health Economics Research in Cancer Screening: Research Opportunities, Challenges, and Future Directions.

Authors:  Ya-Chen Tina Shih; Lindsay M Sabik; Natasha K Stout; Michael T Halpern; Joseph Lipscomb; Scott Ramsey; Debra P Ritzwoller
Journal:  J Natl Cancer Inst Monogr       Date:  2022-07-05

Review 2.  Cancer genetic testing in marginalized groups during an era of evolving healthcare reform.

Authors:  Stephen M Modell; Caitlin G Allen; Amy Ponte; Gail Marcus
Journal:  J Cancer Policy       Date:  2021-02-16

3.  Interrupted Time-Series Analysis of Stereotactic Radiosurgery for Brain Metastases Before and After the Affordable Care Act.

Authors:  Hind A Beydoun; Shuyan Huang; May A Beydoun; Shaker M Eid; Alan B Zonderman
Journal:  Cureus       Date:  2022-01-17

Review 4.  Medicaid Expansions: Probing Medicaid's Filling of the Cancer Genetic Testing and Screening Space.

Authors:  Stephen M Modell; Lisa Schlager; Caitlin G Allen; Gail Marcus
Journal:  Healthcare (Basel)       Date:  2022-06-08

5.  Funding of Hispanic/Latino Health-Related Research by the National Institutes of Health: An Analysis of the Portfolio of Research Program Grants on Six Health Topic Areas.

Authors:  M Larissa Avilés-Santa; Laura Hsu; Tram Kim Lam; S Sonia Arteaga; Ligia Artiles; Sean Coady; Lawton S Cooper; Jennifer Curry; Patrice Desvigne-Nickens; Holly L Nicastro; Adelaida Rosario
Journal:  Front Public Health       Date:  2020-08-28

6.  Cancer genetic testing in marginalized groups during an era of evolving healthcare reform.

Authors:  Stephen M Modell; Caitlin G Allen; Amy Ponte; Gail Marcus
Journal:  J Cancer Policy       Date:  2021-02-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.